Physician and Senior Clinical & Practice Advisor
Substance Abuse and Mental Health Services Administration, Maryland
Robert Baillieu, M.D., M.P.H., F.A.A.F.P. serves as a physician & senior clinical and practice advisor at the Substance Abuse and Mental Health Services Administration (SAMHSA), Center for Substance Abuse Treatment (CSAT). In this role Dr. Baillieu has contributed to work on national policies related to the treatment of opioid use disorder and stimulant use disorder, while also contributing to multiple publications available in the SAMHSA Store. He is also involved in departmental evaluation efforts that seek to assess and promote best practices in treatment.
Dr. Baillieu graduated with honors from the University of Sydney Medical School in Australia and completed residency training in family medicine at The University of Texas Health Science Center in San Antonio, where he was also chief resident. Prior to this, Dr. Baillieu lived in Australia where he undertook training in adult internal medicine. He is a board-certified family physician and a former Robert L. Phillips, Jr., Health Policy Fellow at the American Academy of Family Physicians’ Robert Graham Center and The U.S. Health Resources and Services Administration, Bureau of Primary Care. He holds degrees in medicine, public health, business and modern languages, and has experience in health systems research, policy analysis, community organizing, international business, management, public health, education and medical practice. Dr. Baillieu is also a former assistant professor of clinical family medicine at Georgetown University where he supervised residents and taught classes in policy, advocacy, statistics and clinical medicine. Dr. Baillieu’s research activities have focused on the primary care workforce, health IT and the implementation of best practices at the community level. He has presented at national and international meetings, as well as published in international, peer-reviewed journals.
I do not have any relevant financial / non-financial relationships with any proprietary interests.
Saturday, April 2, 2022
1:30 PM – 2:30 PM ET
